Reckitt research on ‘Ibuprofen, other NSAIDs and COVID‑19’ published in Inflammopharmacology

“At Reckitt, we know self-care is at the heart of health and wellbeing. For the public to benefit from self-care, they need to have trust in the available treatment options and access to appropriate, accurate information. We hope that in publishing this and other scientific research we’re able to increase understanding and ensure people feel equipped to look after themselves and their families.”